Chapter 16 : Enteroviruses and Human Neuromuscular Diseases

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

Enteroviruses and Human Neuromuscular Diseases, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap16-1.gif /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap16-2.gif


Coxsackieviruses, echoviruses, and polioviruses have been implicated in the pathogenesis of human neuromuscular diseases because o f their association with certain acute and chronic acquired myopathies and paralytic motor neuron syndromes. The advent of new molecular techniques has added to both the capability of establishing and the controversy surrounding the role of enteroviruses in various acquired inflammatory muscle diseases and motor neuron syndromes such as polymyositis (PM), dermatomyositis (DM), chronic fatigue syndrome (CFS), postpolio syndrome (PPS), and amyotrophic lateral sclerosis (ALS), each of which is discussed in this chapter. The author has studied muscle biopsy specimens from 39 patients (16 with PM, 12 with DM, and 11 with inclusion body myositis) who fulfilled the strict diagnostic clinicopathologic criteria of active inflammatory myopathy. Two recent studies using in situ hybridization, PCR, and sequence analysis of the amplified product have shown the presence of an enterovirus that differs from the typical strains in the 5' non coding region, suggesting a virus defective or mutated in that region. Biologic plausibility coupled with preliminary laboratory data has focused much attention on the enteroviruses as causative agents in numerous acute and chronic human muscle diseases.

Citation: Dalakas M. 1995. Enteroviruses and Human Neuromuscular Diseases, p 387-398. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch16

Key Concept Ranking

Major Histocompatibility Complex Class I
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Polyacrylamide gel electrophoreses of enterovirus PCR performed on extracted RNA from muscle biopsy samples of patients with inflammatory myopathies and other neuromuscular diseases; also included are positive tissue culture and negative water controls subjected to the same amplification techniques. Lanes 1 through 4 (panel A) and 1 and 2 (panel B) are from patients with PM; lanes 5 through 8 (panel A) and 3 and 4 (panel B) are from patients with DM; lanes 5 through 7 (panel B) are from patients with inclusion body myositis; and lanes 9 and 10 (panel A) and 8 through 10 (panel B) are from patients with other neuromuscular diseases including PPS. Lane P, amplified RNA from poliovirus-infected cell cultures; lane C, amplified RNA from coxsackievirus-infected cultures; lane W, amplification products obtained from water alone; lane MW, molecular weight markers (in thousands). Specific amplification of the expected 154-bp fragment of enteroviral RNA is shown by arrows and was observed in virus-infected cells only; arrowheads indicate lower-molecular-weight bands that are nonspecific products. ( )

Citation: Dalakas M. 1995. Enteroviruses and Human Neuromuscular Diseases, p 387-398. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch16
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

Slot blot hybridization of PCR products hybridized with a 23-mer 32P-labeled oligonucleotide probe. Slots 1 through 6, amplified product from patients with PM; slots 7 through 12, product from patients with DM; slots 13 through 17, product from patients with inclusion body myositis; slots 18 through 23, product from other disease controls including patients with PPS. P1, P2, and P3, amplified products from cell cultures infected with polioviruses 1, 2, and 3, respectively; W, amplified products of water alone; P(s), products from the supernatant of poliovirus-infected cells. Specific hybridization is noted only in virus-infected culture controls [P1, P2, P3, P(s)] but not in muscle biopsy specimens ( ).

Citation: Dalakas M. 1995. Enteroviruses and Human Neuromuscular Diseases, p 387-398. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch16
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Archard, L. C.,, N. E. Bowles,, R. O. Behan,, E. J. Bell , and D. Doyle. 1988. Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J. R. Soc. Med. 81:326329.
2. Behan, P. O.,, W. M. H. Behan,, and E. J. Bell. 1985. The postviral fatigue syndrome—an analysis of the findings in 50 cases. J. Infect. 10:211222.
3. Behan, W. M. H.,, and P. O. Behan. 1993. The role of viral infection in polymyositis, dermatomyositis and chronic fatigue syndrome. Bailliere's Clin. Neurol. 2:637657.
4. Behan, W. M. H.,, and P. O. Behan. 1994. Enteroviruses in chronic fatigue syndrome. Ann. Intern. Med. 120:972973.
5. Ben-Bassat, M.,, and I. Machtey. 1972. Picornavirus-like structures in acute dermatomyositis. Am. J. Clin. Pathol. 58:245.
6. Berlin, B. S.,, N. M. Simon,, and R. N. Bovner. 1974. Myoglobinuria precipitated by viral infection. JAMA 227:1414.
7. Bodensteiner, J. B.,, H. H. Morris,, J. T. Howell,, and S. S. Schochet. 1979. Chronic Echo type 5 virus meningoencephalitis in X-linked hypogammaglobulinemia: treatment with immune plasma. Neurology 29:815.
8. Bowles, N. E.,, V. Dubowitz,, C. A. Swery,, and L. C. Archard. 1987. Dermatomyositis, polymyositis and coxsackie B virus infections. Lancet i:10041007.
9. Chou, S. M.,, and L. Gutmann. 1970. Picornavirus-like crystals in subacute polymyositis. Neurology 10:205.
10. Colbere-Garpin, E.,, C. Christodoulou,, R. Crainic,, and T. Pelletier. 1989. Persistent poliovirus infection of human neuroblastoma cells. Proc. Natl. Acad. Sci. USA 86:75907594.
11. Cronin, M. E.,, L. A. Love,, F. W. Miller,, P.R. McClintock,, and P. H. Plotz. 1988. The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice: viral persistence demonstrated by in situ hybridization. J. Exp. Med. 168:16391648.
12. Cunningham, L.,, N. E. Bowles,, R. J. M. Lane,, V. Dubowitz,, and L. C. Archard. 1990. Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J. Gen. Virol. 71:13991402.
13. Curnen, E. D. 1960. The coxsackie viruses. Pediatr. Clin. N. Am. 7:903.
14. Curnen, E. D.,, E. W. Shaw,, and J. L. Melnick. 1949. Disease resembling nonparalytic poliomyelitis associated with a virus pathogenic for infant mice. JAMA 141:894.
15. Dalakas, M. 1990. Inflammatory myopathies. Curr. Opin. Neurol. Neurosurg. 3:689696.
16. Dalakas, M. 1991. The post-polio syndrome. Curr. Opin. Rheum. 2:901907.
17. Dalakas, M. C. 1988. Polymyositis and Dermatomyositis. Butterworths Publications, Stoneham, Mass.
18. Dalakas, M. C. 1988. Morphological changes in the muscles of patients with post-poliomyelitis neuromuscular symptoms. Neurology 38:99104.
19. Dalakas, M. C. 1990. Oligoclonal bands in postpoliomyelitis muscular atrophy. Ann. Neurol. 3:689696.
20. Dalakas, M. C. 1991. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325:14871498.
21. Dalakas, M. C. 1992. Inflammatory myopathies: pathogenesis and treatment. Neuropharmacology 5:327351.
22. Dalakas, M. C. Pathogenesis of postpolio syndrome: studies on electrophysiology, virology, pathology and immunopathology of muscle and spinal cord. Ann. N.Y.Acad. Sci., in press.
22a. Dalakas, M.C. Unpublished observations.
23. Dalakas, M. C.,, G. Elder,, M. Hallett,, J. Ravitz,, M. Baker,, N. Papadoupolos,, P. Albrecht,, and J. L. Sever. 1986. A long term follow-up study of patients with postpoliomyelitis neuromuscular symptoms. N. Engl. J. Med. 314:959963.
24. Dalakas, M. C.,, and M. Hallett,. 1988. The post-polio syndrome, p. 5194. In F. Plum, (ed.), Advances in Contemporary Neurology. F. A. Davis, Philadelphia.
25. Dalakas, M. C.,, and I. Ilia,. 1991. The post-polio syndrome: concepts in pathogenesis and etiologies, p. 495511. In L. E. Rowland (ed.), Advances in Neurology, vol. 56. Amyotrophic hateral Sclerosis. Raven Press, New York.
26. Dalakas, M. C.,, J. L. Sever,, D. L. Madden,, N. M. Papadopoulis,, I. C. Shedarchi,, P. Albrecht,, and A. Krezlewicz. 1984. Late post-poliomyelitis muscular atrophy: clinical, virological, and immunological studies. Rev. Infect. Dis. 6:S562S567.
27. Davis, L. E.,, D. Bodian,, D. Price,, I. J. Butler,, and J. H. Vickers. 1977. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N. Engl. J. Med. 297:241.
28. De Reuck, J.,, W. De Coster,, and N. Indiradjapa. 1977. Acute viral polymyositis with predominant diaphragm involvement. J. Neurol. Sci. 33:453.
29. Dunnet, J.,, J. Y. Paton,, and C. E. Robertson. 1981. Acute renal failure and coxsackie viral infection. Clin. Nephrol. 16:262.
30. Engel, A. G.,, R. Hohlfeld,, and B. Q. Banker,. 1994. The polymyositis and dermatomyositis syndromes, p. 13351383. In A. G. Engel, and C. Franzini-Armstrong (ed.), Myology. McGraw Hill Book Co., New York.
31. Favara, B. E.,, G. F. Vawter,, R. Wagner, et al. 1967. Familial paroxysmal rhabdomyolysis in children: a myoglobinuric syndrome. Am. J. Med. 42:196.
32. Fukuyama, Y.,, T. Ando,, and J. Yokota. 1977. Acute fulminant myoglobinuric polymyositis with picornavirus-like crystals. J. Neurol. Neurosurg. Psychiatry 40:775.
33. Gauntt, C. J.,, A. L. Higdon,, H. M. Aripze,, M. R. Tamayo,, R. Grawley,, R. D. Henkel,, M. E. A. Periera,, S. M. Tracy,, and M. W. Cunningham. 1993. Epitopes shared between coxsackievirus B3 (VB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin. Immunol. Immunopathol. 68:129134.
34. Ginsberg, H. S., 1990. Picornaviruses, p. 961983. In B. D. David,, R. Dulbecco,, N. H. Eisen,, and H. S. Ginsberg (ed.). Microbiology, 5th ed. Lippincott, Philadelphia.
35. Godman, G. C.,, H. Bunting,, and J. L. Melnick. 1952. The histopathology of coxsackie virus infection in mice. I. Morphologic observations with four different viral types. Am. J. Pathol. 28:223.
36. Gow, J.,, W. M. H. Behan,, G. B. Clements,, C. Woodall,, M. Riding,, and P. O. Behan. 1991. Enteroviral sequences detected by polymerase chain reaction in muscle biopsies of patients with the postviral fatigue syndrome. Br. Med. J. 302:692696.
37. Gow, J. W.,, W. M. H. Behan,, K. Simpson,, F. McGarry,, S. Keir,, and P. O. Behan. 1994. Studies on enterovirus in patients with chronic fatigue syndrome. Clin. Infect. Dis. 18(Suppl.):S126S129.
38. Grenier, B., 1970. Epidemic myalgia (Bornholm disease): epidemiology and clinical description, p. 247. In R. Debre, and J. Cellers (ed.), Clinical Virology: the Evaluation and Management of Human Viral Infections. The W. B. Saunders Co., Philadelphia.
39. Hays, A. P.,, and E. T. Ganboa,. 1994. Acute viral myositis, p. 13081418. In A. G. Engel, and C. Franzini-Armstrong (ed.), Myology II. McGraw Hill Book Co., New York.
40. Holmes, G. P.,, J. E. Kaplan,, N. M. Gantz,, A. L. Komaroff,, L. B. Schonberger,, S. E. Strauss,, J. F. Jones,, R. E. Dubois,, R. C. Cunningham,, and S. Pahwa. 1988. Chronic fatigue syndrome. A working case definition. Ann. Intern. Med. 108:387389.
41. Ilia, I.,, M. Monzon,, and M. C. Dalakas. The role of muscle in the acute polio infection. Ann. N.Y.Acad. Sci., in press.
42. Jenkins, O.,, J. D. Booth,, P. D. Minor,, and J. W. Almond. 1987. The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the picornaviridae. J. Gen. Virol. 68:18351838.
43. Katsuragi, S.,, H. Miyayama,, and H. T. Takeuchi. 1981. Picornavirus-like inclusions in polymyositis-aggregation of glucogen particles of the same size. Neurology 31:14261480.
44. Kibrick, S. 1964. Current status of coxsackie and ECHO viruses in human disease. Prog. Med. Virol. 6:27.
45. Leon-Monzon, M.,, and M. C. Dalakas. 1992. Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies. Ann. Neurol. 32:219222.
46. Levine, B.,, A. Huang,, J. T. Isaacs, et al. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (London) 361:739742.
47. Love, L. A.,, R. L. Leff,, D. D. Frazer,, I. N. Targoft,, M. Dalakas,, P. Plotz,, and F. W. Miller. 1991. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogenous patient groups. Medicine 70:360374.
48. Mailer, H. M.,, D. F. Poward,, R. E. Horowitz,, and B. Portnoy. 1967. Fatal myocarditis associated with ECHO virus, type 22: infection in a child with apparent immunological deficiency. J. Pediatr. 7:204.
49. Maniatis, T.,, E. F. Fritsch,, and J. Sambrook. 1982. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
50. McCartney, R. A.,, J. E. Banatavala,, and E. J. Bell. 1986. Routine use of M-antibody capture ELISA for the serological diagnosis of coxsackie B virus infection. J. Med. Virol. 19:205212.
51. McKinney, R. E.,, S. L. Katz,, and C. M. Wilfert. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9:334356.
52. McManus, B. M.,, L. H. Chow,, J. E. Wilson, et al. 1993. Direct myocardial injury by enteroviruses: a central role in the evolution of murine myocarditis. Clin. Immunol. Immunopathol. 68:159169.
53. Melnick, J. L.,, and G. C. Godman. 1951. Pathogenesis of coxsackie virus infection. Multiplication of virus and evolution of the muscle lesion in mice. J. Exp. Med. 93:27.
54. Monzon, M.,, and M. C. Dalakas. Virological studies in blood, serum and spinal fluid in patients with post-polio syndrome. Ann. N.Y. Acad. Sci., in press.
55. Monzon, M.,, I. Ilia,, and M. C. Dalakas. The expression of poliovirus receptor in normal and pathological muscle, nerve and spinal cord. Ann. N.Y.Acad. Sci., in press.
56. Oldstone, M. B. A. 1989. Viruses can cause disease in the absence of morphological evidence of cell injury: implications for uncovering new diseases in the future. J. Infect. Dis. 139:384.
57. Pezeshkpour, G. H.,, and M. C. Dalakas. 1988. Long term changes in the spinal cord of patients with old poliomyelitis: signs of continuous disease activity. Arch. Neurol. 45:505508.
58. Porter, C. B.,, D. R. Hinthorn,, G. Couchonnal, et al. 1981. Simultaneous streptococcus and picornavirus infection. JAMA 245:1545.
59. Rosenberg, N. L.,, H. A. Rotbart,, M. J. Abzug,, S. P. Ringer,, and M.J. Levin. 1989. Evidence for a novel picornavirus in human dermatomyositis. Ann. Neurol. 26:204209.
60. Rotbart, H. A., 1990. PCR amplification of enteroviruses, p. 372377. In M. A. Innis,, D. H. Gelfand,, J.J. Sninsky,, and T.J. White (ed.), PCR Protocols. Academic Press, San Diego, Calif.
61. Saiki, R. K.,, S.J. Scharf, E Faloona, et al. 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:13501354.
62. Sharief, M. K.,, R. Hentges,, and M. Crardi. 1991. Intrathecal immune response in patients with the postpolio syndrome. N. Engl. J. Med. 325:749755.
63. Strongwater, S. L.,, K. Dorovini-Zis,, R. D. Ball,, and T. J. Schnitzer. 1984. A murine model of polymyositis induced by coxsackievirus Bl (Tucson strain). Arthritis Rheum. 27:433.
63a. Swanink, C. M. A.,, W. J. G. Melchers,, J. W. M. van der Meer,, J. H. M. M. Vercoulen,, G. Bleijenberg,, J. F. M. Fennis,, and J. M. D. Galama. 1994. Enteroviruses and the chronic fatigue syndrome. Clin. Infect. Dis. 19:860864.
64. Sylvest, E. 1934. Epidemic Myalgia: Bornholm Disease. Oxford University Press, London.
65. Tang, T. T.,, G. V. Sedmak,, K. A. Siegesmund,, and S. R. McCreadie. 1975. Chronic myopathy associated with coxsackievirus type A. A combined electronmicroscopical and viral isolation study. N. Engl. J. Med. 292:608611.
66. Targoff, I. N.,, F. C. Arnett,, and M. Reichlin. 1988. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rlieum. 31:515524.
67. Travers, R. L.,, G. R. V. Hughes,, G. Cambridge,, and J. R. Sewell. 1977. Coxsackie B neutralization titers in polymyositis dermatomyositis. Lancet i:1268.
68. Vella, C.,, C. L. Brown,, and D. A. McCarthy. 1992. Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infection.,J. Gen. Virol. 73:13871394.
69. Weller, A. H.,, K. Simpson,, M. Hersum,, N. V. Hooten,, and S. A. Huber. 1989. Coxsackievirus B3-induced myocarditis: virus receptor antibodies modulate myocarditis. J. Immunol. 143:18431850.
70. Wilfert, C. M.,, R. H. Buckley,, T. Mohanakumar,, J. F. Griffith,, S. L. Katz,, J. K. Whisnant,, P. A. Eggleston,, M. Moore,, E. Treadwell,, M. N. Oxman,, and F. N. Rosen. 1977. Persistent and fatal central nervous system echovirus infections in patients with agammaglobulinemia. N. Engl. J. Med. 296:1485.
71. Woodall, C. J.,, M. H. Riding,, D. I. Graham,, and G. B. Clemens. 1994. Sequences specific for enteroviruses detected in spinal cord from patients with motor neuron diseases. Br. Med. J. 308:13411343.
72. Yousef, G. E.,, E.J. Bell,, G. F. Mann,, V. Murugesan,, D. G. Smith,, R. A. McCartney,, and J. F. Mowbray. 1988. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet i:146149.
73. Yousef, G. E.,, D. A. Isenberg,, and J. F. Mowbray. 1990. Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis. Ann. Rheum. Dis. 49:310315.
74. Ytterberg, S. R.,, M. L. Mahowald,, and R. P. Messner. 1987. Coxsackievirus Bl-induced polymyositis: lack of disease expression in nu/ nu mice. J. Clin. Invest. 80:499.
75. Ytterberg, S. R.,, M. L. Mahowald,, and R. P. Messner. 1988. T cells are required for coxsackie Bl induced murine polymyositis. J. RJieumatol. 15:475.
76. Zoll, J.,, P. Jongen,, J. Galama,, F. V. Kuppeveld,, and W. Melchers. 1993. Coxsackievirus Bl-induced murine myositis: no evidence for viral persistence. J. Gen. Virol. 74:20712076.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error